Skip to main content
SpringerLink
Log in

Hypertensie door COX-2-remmers

  • Farmacotherapie
  • Published:
Medisch-Farmaceutische Mededelingen

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  • Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, et al.The Effect of Cyclooxygenase-2-Inhibitors and Non Steroidal Anti-Inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes Mellitus. Arch Intern Med. 2005;165:161-68.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/

    A. C. M. Vingerhoeds

Authors
  1. A. C. M. Vingerhoeds
    View author publications

    You can also search for this author in PubMed Google Scholar

Verkrijgbaar

Verkrijgbaar

Naproxen. In Nederland in de handel als zodanig en onder de merknamen Aleve (OTC!), Naprocoat®, Naprovite® en Nycopren®.

Celecoxib. In Nederland in de handel als Celebrex®.

Rofecoxib. In Nederland in de handel geweest onder de merknaam Vioxx®/inmiddels wereldwijd uit de circulatie genomen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vingerhoeds, A.C.M. Hypertensie door COX-2-remmers. MFAM 43, 158 (2005). https://doi.org/10.1007/BF03058619

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03058619

Search

Navigation